Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. - Wikidata - awgldk - TriplyDB

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate.

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate.

http://www.wikidata.org/entity/Q37230480

about

Inhibitory effect of Yukmijihwang-tang, a traditional herbal formula against testosterone-induced benign prostatic hyperplasia in rats.Benign prostatic hyperplasia: An overview of existing treatment.An overview of prostate diseases and their characteristics specific to Asian men.Can glycoprofiling be helpful in detecting prostate cancer?Review of Prostate Anatomy and Embryology and the Etiology of Benign Prostatic Hyperplasia.Musulju improves benign prostatic hyperplasia by regulating inflammatory and apoptotic proteins.Cynanchum wilfordii Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia by Regulating 5α-Reductase and Androgen Receptor Activities in a Rat Model.A herbal formula, comprising and bee-pollen, inhibits development of testosterone-induced benign prostatic hyperplasia in male Wistar rats The Effect of Capsule on Testosterone-Induced Benign Prostatic Hyperplasia in Rats

P2860

Q34240687-97A82CC5-92E6-4F05-AE03-5D5005DE4682 Q34706497-5ECCC826-6C87-460E-85C0-E40F9D7178E3 Q37037794-9BB676E2-75B8-4C51-B211-328DAD6E4B08 Q38852467-DC209F2D-0878-43C6-8863-350BD4CF194E Q38913900-1B09F5D1-1E37-4DA0-B174-096F0307F905 Q42371431-71E885C0-4D52-425B-A7B2-EBA91E37D05F Q45339114-EEFC03E4-054B-4329-9A5F-AB97D1B063D6 Q57193380-80D69294-5803-4677-BEC7-84422E269293 Q58604101-DCB8CC17-E959-49B3-8178-B8D14E7AB8FA

P2860

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate.

http://www.wikidata.org/entity/Q37230480

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 09 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Combination therapy with dutas ...... symptomatic enlarged prostate.

@en

Combination therapy with dutas ...... symptomatic enlarged prostate.

@nl

type

label

Combination therapy with dutas ...... symptomatic enlarged prostate.

@en

Combination therapy with dutas ...... symptomatic enlarged prostate.

@nl

prefLabel

Combination therapy with dutas ...... symptomatic enlarged prostate.

@en

Combination therapy with dutas ...... symptomatic enlarged prostate.

@nl

P1433

Q37230480-B0D93DEF-A39D-472D-8DDF-99563F28554B

P1476

Q37230480-C287AB93-65D3-4911-A023-1EE458F5E427

P2093

Q37230480-63B8ADEE-CC15-4F20-8E2D-BE83A604BE0E

Q37230480-883B91CB-BBB1-479D-92C0-BA7915B1F1E0

P2860

Q37230480-0B63DA0E-E9B0-489E-8FA0-47245B604D39

Q37230480-15A6D64E-EE51-4301-82F5-9CB4FFD14C7A

Q37230480-227C7806-2DEF-4F73-BBF1-A53F93A8B4F5

Q37230480-2AE57EA8-A90A-4CAA-8B51-4E7BC92201E7

Q37230480-35351176-7CDD-4965-A136-3A656814236C

Q37230480-35B464AC-2DE3-433D-A3FD-6E8100B33799

Q37230480-38BFCAA8-EE60-4C2D-9E4E-07282A2FF573

Q37230480-55D3C93E-BDB9-45BE-B285-59D927EDB860

Q37230480-62B6067E-44A9-4400-9771-811A38A3D322

Q37230480-8485379F-314B-4FFD-8905-C30E6E73C7B4

P304

Q37230480-EADEC889-6533-488A-BCDF-B94CBC311D17

P31

Q37230480-81A9A73C-4E17-4232-B35B-0534D11DA6EE

P356

Q37230480-59A9D407-525E-4143-B670-55CA627EDBB3

P407

Q37230480-F2918A94-1B2C-4B92-A4F6-BD340C0E65C0

P478

Q37230480-E5938BC8-8A42-46AF-B23E-B0D5463B3601

P577

Q37230480-A7D09D57-B2BD-4AF8-8FBE-2E6F3B5DC030

P698

Q37230480-4AB11F8D-B08B-4165-BD4F-B1837BD8A06E

P921

Q37230480-5FDCD255-CC8C-4FD2-A443-548DCAF89229

Q37230480-AF952F5C-6DE9-4514-9611-8C89AD2C3682

Q37230480-CB747F68-8858-4AA6-BE96-FF340D714F5D

P932

Q37230480-8C99EB53-440E-4FA4-95EE-42AD250C6D8D

P356

P1433

Clinical Interventions in Aging

P1476

Combination therapy with dutas ...... symptomatic enlarged prostate

@en

P2093

J Miller

http://www.w3.org/2001/XMLSchema#string

T H Tarter

http://www.w3.org/2001/XMLSchema#string

P2860

The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia.

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.

The influence of finasteride on the development of prostate cancer.

Efficacy of neoadjuvant bicalutamide and dutasteride as a cytoreductive regimen before prostate brachytherapy.

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.

Does finasteride alter the pathology of the prostate and cancer grading?

Chemoprevention using dutasteride: the REDUCE trial.

Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging.

Long-term efficacy and safety of tamsulosin for benign prostatic hyperplasia.

P304

251-258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CIA.S4102

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19554096

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

polycyclic compound

P932

2697590

http://www.w3.org/2001/XMLSchema#string